Strategic Forecast for the Circulating Tumor Cells Industry: Market Outlook 2025-2034

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Circulating Tumor Cells Market Size Growth Forecast: What to Expect by 2025?
The market size for circulating tumor cells has seen significant expansion in the past few years. It is predicted to rise from $11.9 billion in 2024 to $13.37 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.4%. Factors such as the increase in cancer diagnosis and prevalence, the proven clinical advantage in cancer staging, the rise of liquid biopsy, preferences of patients for less invasive tests, regulatory approval for liquid biopsies, and the emphasized need for early cancer detection can all be attributed to the historical growth.

How Will the Circulating Tumor Cells Market Size Evolve and Grow by 2029?
In the coming years, a rapid expansion in the circulating tumor cells market size is anticipated. The market is projected to surge to $21.68 billion in 2029, with a compound annual growth rate (CAGR) of 12.8%. The acceleration during the forecasted period can be credited to point-of-care CTC testing, embracing microfluidics, targeting rare types of cancer, standardization of CTC tests, an increase in CTC-related clinical trials, and economic growth in emerging markets. Major trends forecasted for the period encompass innovations in isolating circulating tumor cells, an influx of government investments for CTC research, enhancements in spotting circulating tumor cells, usage of liquid biopsy for tracking cancer, integration of single-cell analysis, and the fusion with artificial intelligence (AI) technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/circulating-tumor-cells-global-market-report

What Drivers Are Propelling the Growth of Circulating Tumor Cells Market Forward?
The escalating occurrence of cancer is anticipated to drive the growth of the circulating tumor cells market. Cancer is a condition characterized by the uncontrolled growth of some cells in the body, spreading to other areas. These circulating tumor cells aid in early cancer detection and diagnosis, hence the increase in cancer prevalence enhances the market growth for these cells. For instance, forecasts from the American Cancer Society Journals, a voluntary health organization based in the US, suggested in January 2023 that there would be around 1,958,310 newly diagnosed cancer cases and an expected 609,820 cancer-related fatalities in the United States. This rising prevalence of cancer is the key factor propelling the growth of the circulating tumor cells market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8950&type=smp

Which Emerging Trends Are Transforming the Circulating Tumor Cells Market in 2025?
The increasing popularity of product innovations in the circulating tumor cells market is a major trend. Numerous prominent corporations involved in this market are concentrating on the creation of novel products to secure their market position. For example, in June 2024, Bio-Rad Laboratories, Inc., a medical laboratory based in the US, introduced Celselect Slides 2.0. This product is engineered to augment the collection of scarce cells and circulating tumor cells (CTCs), thus amplifying the precision and productivity of cell studies for clinical and research use.

What Are the Key Segments in the Circulating Tumor Cells Market?
The circulating tumor cells market covered in this report is segmented -

1) By Product: Kits And Reagents, Blood Collection Tubes, Devices Or Systems
2) By Technology: CTC Enrichment, CTC Detection, CTC Analysis
3) By Specimen: Blood, Bone Marrow, Other Body Fluids
4) By Application: Clinical Or Liquid Biopsy, Research

Subsegments:
1) By Kits And Reagents: Cell Enrichment Kits, Detection Kits, Nucleic Acid Isolation Kits
2) By Blood Collection Tubes: Standard Blood Collection Tubes, Specialized Blood Collection Tubes
3) By Devices Or Systems: Microfluidic Devices, Automated Cell Capture Systems, Imaging Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8950&type=smp

Who Are the Key Players Shaping the Circulating Tumor Cells Market's Competitive Landscape?
Major companies operating in the circulating tumor cells market include Precision Medicine Group LLC, Bio-Techne Corporation, BIOCEPT Inc., Creativ MicroTech Inc., Fluxion Biosciences Inc., Ikonisys Inc., Qiagen N.V., ScreenCell SAS, STEMCELL Technologies Inc., Sysmex Corporation, Aviva Biosciences Corporation, LungLife AI Inc., Miltenyi Biotec GmbH, Menarini Silicon Biosystems S.p.A., Canopus Bioscience Ltd., IVDiagnostics Inc., BioFluidica Inc., Biolidics Limited, Rarecells Diagnostics SAS, LineaRx Inc., Thermo Fisher Scientific Inc., Greiner Bio-One International GmbH, Stanford Research Institute International, Agilent Technologies Inc., Resolution Bioscience Inc., Cynvenio Biosystems Inc., ApoCell Inc., Clearbridge BioMedics Pte. Ltd., Celsee Inc., RareCyte Inc., On-chip Biotechnologies Co. Ltd.

What Geographic Markets Are Powering Growth in the Circulating Tumor Cells Market?
North America was the largest region in the circulating tumor cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the circulating tumor cells market during the forecast period. The regions covered in the circulating tumor cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8950

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.